Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kissei Pharmaceutical Co., Ltd.

Clinical trials sponsored by Kissei Pharmaceutical Co., Ltd., explained in plain language.

Kissei Pharmaceutical Co., Ltd. 4547 TOKYO

Japanese pharmaceutical company developing drugs for urology, diabetes, and rare diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 2 Completed 3

New hope for tough leukemia? tiny trial tests targeted pill

Disease control Recruiting now

This study tests an oral drug called olutasidenib in 3 Japanese patients whose acute myeloid leukemia (AML) has a specific IDH1 gene mutation and has not responded to or returned after other treatments. The main goal is to check safety, but researchers will also see if the drug c…

Phase: PHASE2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC